)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Harvard Apparatus Regenerative Technology (HRGN) investor relations material
Harvard Apparatus Regenerative Technology Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary7 Nov, 2025
Executive summary
Q3 2025 results reached the high end of guidance, with improved profitability and liquidity driven by cost efficiencies and positive cash flow generation.
Focus remains on accelerating product adoption, maintaining financial discipline, and strengthening the capital structure through refinancing or repayment of existing credit agreements.
Product revenue growth in consumer health was driven by new offerings and expanded distribution, while clinical-stage esophageal implant trials faced recruitment delays.
Substantial operating losses and accumulated deficit persist, with additional capital required to fund operations beyond Q4 2025.
Financial highlights
Revenue for Q3 2025 was $20.6 million, at the high end of the $19–$21 million guidance range, but down from $22.0 million in Q3 2024.
Gross margin improved to 58.4%, exceeding guidance and up from 58.1% in Q3 2024; product revenue in consumer health was $123,000, up 108% year-over-year, with a gross margin of 9%.
Adjusted EBITDA rose to $2.0 million (9.6% of revenue) from $1.3 million (6.0%) in Q3 2024, driven by reduced operating expenses.
Cash provided by operations was $6.8 million, a significant improvement from $(0.3) million in the same period last year; cash and cash equivalents as of September 30, 2025, were $6.8 million.
Net loss for Q3 2025 was $(1.2) million, improved from $(4.8) million in Q3 2024; in another segment, net loss was $1.7 million, a 9% improvement year-over-year.
Outlook and guidance
Q4 2025 revenue guidance is $22.5–$24.5 million, with gross margin expected between 58–60%.
Improved demand and backlog support confidence in continued financial improvement for Q4.
Operating cash on hand expected to fund expenses into Q4 2025, but additional financing is necessary to continue operations.
Ongoing focus on growing the core business and restructuring the balance sheet for sustainable long-term sales and profitability.
Q4 2025 funding strategy
Clinical trial recruitment mitigation progress
Consumer Health segment profit drivers
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Harvard Apparatus Regenerative Technology earnings date
Q4 202530 Mar, 2026
Next Harvard Apparatus Regenerative Technology earnings date
Q4 202530 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Harvard Apparatus Regenerative Technology Inc is a U.S.-based biotechnology company developing regenerative medicine solutions. The company focuses on bioengineered implants for airway reconstruction using scaffold and cell technologies. Its research is aimed at treating life-threatening conditions such as tracheal damage and lung diseases. The company is headquartered in Holliston, Massachusetts, and its shares are listed on the OTCQB.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage